Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
about
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightPathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogenFatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIVBiochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in miceSynchronous multifocal necrotizing fasciitis prognostic factors: a retrospective case series study in a single centerSupplementation with the extract of schisandrae fructus pulp, seed, or their combination influences the metabolism of lipids and glucose in mice fed with normal and hypercholesterolemic dietNAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.rs7903146 polymorphism at transcription factor 7 like 2 gene is associated with total cholesterol and lipoprotein profile in HIV/hepatitis C virus-coinfected patients.Nonalcoholic Hepatic Steatosis Is a Strong Predictor of High-Risk Coronary-Artery Plaques as Determined by Multidetector CT.Cirrhosis-induced morphological changes in the retina: possible role of endogenous opioid.Short Communication: Coronary Heart Disease Risk by Framingham Risk Score in Hepatitis C and HIV/Hepatitis C-Coinfected Persons.Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.Plasma lipid profiling of different types of hepatic fibrosis induced by carbon tetrachloride and lomustine in ratsAdditive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.Ethnicity matters: A Systematic Review and Meta-Analysis of the Non-Linear Relationship Between Alcohol Consumption and Prevalence and Incidence of Hepatic SteatosisThe RNA-binding protein vigilin regulates VLDL secretion through modulation of Apob mRNA translationPharmacotherapy of acute alcoholic hepatitis in clinical practice.Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease.The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans.Chronic hepatitis C virus infection is associated with increased risk of preterm birth: a meta-analysis of observational studies.Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.Impact of serum levels of interleukin-6 and adiponectin on all-cause, liver-related, and liver-unrelated mortality in chronic hepatitis C patients.Gamma glutamyl transferase: A novel cardiovascular outfit for an old liver test.Association between non-alcoholic hepatic steatosis and hyper reactive blood pressure response on the exercise treadmill test.The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candiAssociations of Fatty Liver Disease with Hypertension, Diabetes, and Dyslipidemia: Comparison between Alcoholic and Nonalcoholic Steatohepatitis.Nonalcoholic fatty liver disease: Evolving paradigms.NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk.Association of Vitamin E Levels with Metabolic Syndrome, and MRI-Derived Body Fat Volumes and Liver Fat Content.Clinical relevance of liver histopathology and different histological classifications of NASH in adults.Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease?
P2860
Q26752583-D7611587-1A97-4986-A1FA-79875F455A34Q26861095-28B8D052-7A99-4E10-8FD9-608F20F06CA2Q28079826-2A143A2D-8756-4451-82FB-DE4246F7E71FQ28468601-A6F570AF-A8CC-496F-A8B4-2DB8193E2C55Q33436282-B3B1327D-FF76-4C0C-8917-9F7206DE5453Q33614303-9B3853F4-DD3E-45DE-8212-9ACCE83A09F6Q33844463-F2A87048-E322-4B0D-A60D-DA7443068457Q35142495-77F1CEC5-14C6-49CC-A6F3-900C023B9633Q35678746-5F31A84C-8417-490C-9C99-F8AE5B910FADQ35756430-E81D5144-E6D6-403B-90EA-7D02FD6186EBQ35861534-59941E95-F62E-417F-B71E-E2C0E65B8DE3Q36059065-580E9259-1BD9-4CDF-A612-98D9B0ADC520Q36790434-10DD4C14-E4AD-4968-AE46-DF8F7EDF525DQ36846905-F77537E0-0868-4716-802A-EF1D97311A14Q37035153-ADD155F4-17FA-40DB-9B88-6835D305EB0BQ37315134-5B7CEFDA-009B-4F98-99C5-40201B23D0C1Q37617944-C339F484-FD06-4514-BC32-C8351E2E0ED7Q38261236-F1BA526A-F967-4114-B384-67A3C664BA09Q38752520-56D83CE1-A4F4-4405-ABCE-15E085C940BDQ38994989-A32B2FC1-839A-4280-AAAC-1F2AEE6B9EA4Q39021862-2600A97A-115E-436B-BB78-69BC98ACEC9EQ39138286-816CD426-6241-46B3-8C08-DF60B4DB97DCQ39906621-1133659A-8AC6-4F69-8BBA-DD8AEF128EBBQ40080468-67D696B0-707D-4DF8-B0C6-2F8C8D48B3B8Q40088550-E6BBF7B8-47B1-4AEF-8EC5-40EF2BEB01F4Q41623033-6A72F331-C947-4CD4-A44B-B7F966F67B60Q42695154-71DFA5BC-B98D-41C1-9A64-0B8C36C3A35EQ43546902-0BD84CE2-7948-4D29-A9A7-4FB12DF6242CQ47117831-14C29C88-BC61-43CA-869F-11A5C499E8F4Q47581786-24D19E1D-48C8-4EAE-A76F-733B20A5D1E8Q49608904-8AD7BD2C-A787-4A33-99A1-8A99E1D1DE5EQ49805564-FE16E539-47A2-46C4-8B7D-332DE4C5477A
P2860
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Cardiovascular risk, lipidemic ...... sease due to varying etiology.
@en
type
label
Cardiovascular risk, lipidemic ...... sease due to varying etiology.
@en
prefLabel
Cardiovascular risk, lipidemic ...... sease due to varying etiology.
@en
P2093
P50
P1433
P1476
Cardiovascular risk, lipidemic ...... sease due to varying etiology.
@en
P2093
P304
P356
10.1016/J.ATHEROSCLEROSIS.2013.10.030
P577
2013-11-06T00:00:00Z